Free Trial

OptiBiotix Health (OPTI) Competitors

OptiBiotix Health logo
GBX 10.50 +0.50 (+5.00%)
As of 10:16 AM Eastern

OPTI vs. CYAN, PHE, REVB, OKYO, ALT, IGAS, CRDL, IDP, IRON, and JAN

Should you be buying OptiBiotix Health stock or one of its competitors? The main competitors of OptiBiotix Health include CyanConnode (CYAN), PowerHouse Energy Group (PHE), Revolution Beauty Group (REVB), OKYO Pharma (OKYO), Altitude Group (ALT), IGas Energy (IGAS), Cordel Group (CRDL), InnovaDerma (IDP), Ironveld (IRON), and Jangada Mines (JAN). These companies are all part of the "pharmaceutical products" industry.

OptiBiotix Health vs. Its Competitors

CyanConnode (LON:CYAN) and OptiBiotix Health (LON:OPTI) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

OptiBiotix Health has lower revenue, but higher earnings than CyanConnode. CyanConnode is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CyanConnode£14.18M1.77-£4.72M-£0.01-609.83
OptiBiotix Health£870K12.47-£3.09M-£0.02-570.65

6.7% of CyanConnode shares are held by institutional investors. Comparatively, 0.4% of OptiBiotix Health shares are held by institutional investors. 50.1% of CyanConnode shares are held by company insiders. Comparatively, 26.6% of OptiBiotix Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, CyanConnode's average media sentiment score of 0.00 equaled OptiBiotix Health'saverage media sentiment score.

Company Overall Sentiment
CyanConnode Neutral
OptiBiotix Health Neutral

CyanConnode has a net margin of -20.45% compared to OptiBiotix Health's net margin of -524.43%. CyanConnode's return on equity of -28.94% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
CyanConnode-20.45% -28.94% -9.06%
OptiBiotix Health -524.43%-36.76%-13.93%

CyanConnode has a beta of 1.6, suggesting that its stock price is 60% more volatile than the S&P 500. Comparatively, OptiBiotix Health has a beta of 1.71, suggesting that its stock price is 71% more volatile than the S&P 500.

Summary

CyanConnode beats OptiBiotix Health on 7 of the 11 factors compared between the two stocks.

Get OptiBiotix Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPTI vs. The Competition

MetricOptiBiotix HealthBiotechnology IndustryMedical SectorLON Exchange
Market Cap£10.85M£238.03M£5.78B£2.58B
Dividend YieldN/A3.78%5.73%5.30%
P/E Ratio-570.6541.2574.865,404.14
Price / Sales12.474,870.38543.7896,701.95
Price / Cash8.6813.1925.8127.93
Price / Book1.35126.0413.258.78
Net Income-£3.09M-£90.99M£3.29B£5.89B
7 Day Performance2.44%2.35%0.47%0.56%
1 Month Performance-12.32%21.81%4.60%44.71%
1 Year Performance-45.45%657.62%73.42%174.03%

OptiBiotix Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPTI
OptiBiotix Health
N/AGBX 10.50
+5.0%
N/A-48.1%£10.85M£870K-570.651Gap Up
CYAN
CyanConnode
N/AGBX 7.39
+1.9%
N/A-13.1%£26.00M£14.18M-631.45100Gap Down
PHE
PowerHouse Energy Group
N/AGBX 0.58
-2.5%
N/A-47.3%£25.94M£499.41K-527.274Gap Down
REVB
Revolution Beauty Group
N/AGBX 3
-5.1%
N/A-85.1%£24.59M£142.58M-55.5610Positive News
High Trading Volume
OKYO
OKYO Pharma
N/AN/AN/AN/A£23.24MN/A-140.007Gap Down
ALT
Altitude Group
N/AGBX 27
flat
N/A-16.9%£19.69M£37.26M1,666.6750Positive News
Insider Trade
High Trading Volume
IGAS
IGas Energy
N/AN/AN/AN/A£18.97M£59.17M-148.90100Gap Up
CRDL
Cordel Group
N/AGBX 6.40
+7.1%
N/A+14.8%£13.88M£4.76M-1,560.9835Positive News
Insider Trade
Gap Down
IDP
InnovaDerma
N/AN/AN/AN/A£8.14M£9.82M-3.878,720
IRON
Ironveld
N/AGBX 0.05
flat
N/A+12.2%£7.28M-£173K-115.0030Gap Down
JAN
Jangada Mines
N/AGBX 0.80
-3.0%
N/A-36.0%£5.12MN/A-170.211Gap Down

Related Companies and Tools


This page (LON:OPTI) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners